These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24325392)

  • 21. Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells.
    Andrei G; Snoeck R; Schols D; De Clercq E
    Oncol Res; 2000; 12(9-10):397-408. PubMed ID: 11697818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of fibroblast growth factor-2-induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir.
    Liekens S; Neyts J; De Clercq E; Verbeken E; Ribatti D; Presta M
    Cancer Res; 2001 Jul; 61(13):5057-64. PubMed ID: 11431341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and treatment of cidofovir-resistant vaccinia (WR strain) virus infections in cell culture and in mice.
    Smee DF; Wandersee MK; Bailey KW; Hostetler KY; Holy A; Sidwell RW
    Antivir Chem Chemother; 2005; 16(3):203-11. PubMed ID: 16004083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia.
    Andrei G; Topalis D; De Schutter T; Snoeck R
    Antiviral Res; 2015 Feb; 114():21-46. PubMed ID: 25446403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral activity of cidofovir against telomerase-specific replication-selective oncolytic adenovirus, OBP-301 (Telomelysin).
    Ouchi M; Kawamura H; Urata Y; Fujiwara T
    Invest New Drugs; 2009 Jun; 27(3):241-5. PubMed ID: 18754077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ribonucleotide reductase inhibitors enhance cidofovir-induced apoptosis in EBV-positive nasopharyngeal carcinoma xenografts.
    Wakisaka N; Yoshizaki T; Raab-Traub N; Pagano JS
    Int J Cancer; 2005 Sep; 116(4):640-5. PubMed ID: 15818619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines.
    Andrei G; Snoeck R; Piette J; Delvenne P; De Clercq E
    Oncol Res; 1998; 10(10):523-31. PubMed ID: 10338155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.
    Quenelle DC; Collins DJ; Kern ER
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3275-80. PubMed ID: 14506041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced efficacy of cidofovir combined with vaccinia immune globulin in treating progressive cutaneous vaccinia virus infections in immunosuppressed hairless mice.
    Smee DF; Dagley A; Downs B; Hagloch J; Tarbet EB
    Antimicrob Agents Chemother; 2015 Jan; 59(1):520-6. PubMed ID: 25385098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral activity of Cidofovir on a naturally human papillomavirus-16 infected squamous cell carcinoma of the head and neck (SCCHN) cell line improves radiation sensitivity.
    Sirianni N; Wang J; Ferris RL
    Oral Oncol; 2005 Apr; 41(4):423-8. PubMed ID: 15792615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cidofovir Diphosphate Inhibits Adenovirus 5 DNA Polymerase via both Nonobligate Chain Termination and Direct Inhibition, and Polymerase Mutations Confer Cidofovir Resistance on Intact Virus.
    Chamberlain JM; Sortino K; Sethna P; Bae A; Lanier R; Bambara RA; Dewhurst S
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of herpes simplex virus disease in patients who are receiving cidofovir.
    Wyles DL; Patel A; Madinger N; Bessesen M; Krause PR; Weinberg A
    Clin Infect Dis; 2005 Sep; 41(5):676-80. PubMed ID: 16080090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir.
    Kern ER; Hartline C; Harden E; Keith K; Rodriguez N; Beadle JR; Hostetler KY
    Antimicrob Agents Chemother; 2002 Apr; 46(4):991-5. PubMed ID: 11897580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cidofovir in the treatment of HPV-associated lesions.
    Snoeck R; Andrei G; De Clercq E
    Verh K Acad Geneeskd Belg; 2001; 63(2):93-120, discussion 120-2. PubMed ID: 11436421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cidofovir inhibits genome encapsidation and affects morphogenesis during the replication of vaccinia virus.
    Jesus DM; Costa LT; Gonçalves DL; Achete CA; Attias M; Moussatché N; Damaso CR
    J Virol; 2009 Nov; 83(22):11477-90. PubMed ID: 19726515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The nucleotide analog cidofovir suppresses basic fibroblast growth factor (FGF2) expression and signaling and induces apoptosis in FGF2-overexpressing endothelial cells.
    Liekens S; Gijsbers S; Vanstreels E; Daelemans D; De Clercq E; Hatse S
    Mol Pharmacol; 2007 Mar; 71(3):695-703. PubMed ID: 17158200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir.
    Lu M; Suen J; Frias C; Pfeiffer R; Tsai MH; Chuang E; Zeichner SL
    J Virol; 2004 Dec; 78(24):13637-52. PubMed ID: 15564474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro.
    Beadle JR; Hartline C; Aldern KA; Rodriguez N; Harden E; Kern ER; Hostetler KY
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2381-6. PubMed ID: 12121908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel anti-metastatic action of cidofovir mediated by inhibition of E6/E7, CXCR4 and Rho/ROCK signaling in HPV tumor cells.
    Amine A; Rivera S; Opolon P; Dekkal M; Biard DS; Bouamar H; Louache F; McKay MJ; Bourhis J; Deutsch E; Vozenin-Brotons MC
    PLoS One; 2009; 4(3):e5018. PubMed ID: 19325708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative whole genome sequence analysis of wild-type and cidofovir-resistant monkeypoxvirus.
    Farlow J; Ichou MA; Huggins J; Ibrahim S
    Virol J; 2010 May; 7():110. PubMed ID: 20509894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.